WallStreetZenWallStreetZen

NASDAQ: DERM
Journey Medical Corp Stock Forecast, Predictions & Price Target

Analyst price target for DERM

Based on 1 analyst offering 12 month price targets for Journey Medical Corp.
Min Forecast
$8.50+55.39%
Avg Forecast
$8.50+55.39%
Max Forecast
$8.50+55.39%

Should I buy or sell DERM stock?

Based on 1 analyst offering ratings for Journey Medical Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DERM stock forecasts and price targets.

DERM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-16

1 of 1

Forecast return on equity

Is DERM forecast to generate an efficient return?
Company
29.36%
Industry
38.6%
Market
81.56%
DERM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DERM forecast to generate an efficient return on assets?
Company
5.71%
Industry
17.34%
DERM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DERM earnings per share forecast

What is DERM's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.02
Avg 2 year Forecast
-$0.68
Avg 3 year Forecast
-$0.24

DERM revenue forecast

What is DERM's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$55.5M-30.62%
Avg 2 year Forecast
$60.7M-24.07%
Avg 3 year Forecast
$76.5M-4.42%
DERM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DERM revenue growth forecast

How is DERM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-2.25%
Industry
7.74%
Market
9.88%
DERM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DERM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DERM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
DERM$5.47$8.50+55.39%Strong Buy
ASRT$1.16$2.88+147.84%Strong Buy
INCR$2.15N/AN/A
CRDL$1.89$8.50+349.74%Strong Buy
OPTN$1.13$4.00+253.98%Strong Buy

Journey Medical Stock Forecast FAQ

Is Journey Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DERM) stock is to Strong Buy DERM stock.

Out of 1 analyst, 1 (100%) are recommending DERM as a Strong Buy, 0 (0%) are recommending DERM as a Buy, 0 (0%) are recommending DERM as a Hold, 0 (0%) are recommending DERM as a Sell, and 0 (0%) are recommending DERM as a Strong Sell.

If you're new to stock investing, here's how to buy Journey Medical stock.

What is DERM's earnings growth forecast for 2024-2026?

(NASDAQ: DERM) Journey Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 20.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.96%.

Journey Medical's earnings in 2024 is -$4,159,000.On average, 1 Wall Street analyst forecast DERM's earnings for 2024 to be -$20,413,154, with the lowest DERM earnings forecast at -$20,413,154, and the highest DERM earnings forecast at -$20,413,154. On average, 1 Wall Street analyst forecast DERM's earnings for 2025 to be -$13,608,769, with the lowest DERM earnings forecast at -$13,608,769, and the highest DERM earnings forecast at -$13,608,769.

In 2026, DERM is forecast to generate -$4,803,095 in earnings, with the lowest earnings forecast at -$4,803,095 and the highest earnings forecast at -$4,803,095.

What is DERM's revenue growth forecast for 2024-2026?

(NASDAQ: DERM) Journey Medical's forecast annual revenue growth rate of -2.25% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.88%.

Journey Medical's revenue in 2024 is $79,998,000.On average, 1 Wall Street analysts forecast DERM's revenue for 2024 to be $1,110,715,728, with the lowest DERM revenue forecast at $1,110,715,728, and the highest DERM revenue forecast at $1,110,715,728. On average, 1 Wall Street analysts forecast DERM's revenue for 2025 to be $1,215,583,303, with the lowest DERM revenue forecast at $1,215,583,303, and the highest DERM revenue forecast at $1,215,583,303.

In 2026, DERM is forecast to generate $1,530,186,028 in revenue, with the lowest revenue forecast at $1,530,186,028 and the highest revenue forecast at $1,530,186,028.

What is DERM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DERM) forecast ROA is 5.71%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 17.34%.

What is DERM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DERM price target, the average DERM price target is $8.50, with the highest DERM stock price forecast at $8.50 and the lowest DERM stock price forecast at $8.50.

The Wall Street analyst predicted that Journey Medical's share price could reach $8.50 by Feb 16, 2025. The average Journey Medical stock price prediction forecasts a potential upside of 55.39% from the current DERM share price of $5.47.

What is DERM's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: DERM) Journey Medical's current Earnings Per Share (EPS) is -$0.20. On average, analysts forecast that DERM's EPS will be -$1.02 for 2024, with the lowest EPS forecast at -$1.02, and the highest EPS forecast at -$1.02. On average, analysts forecast that DERM's EPS will be -$0.68 for 2025, with the lowest EPS forecast at -$0.68, and the highest EPS forecast at -$0.68. In 2026, DERM's EPS is forecast to hit -$0.24 (min: -$0.24, max: -$0.24).

What is DERM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DERM) forecast ROE is 29.36%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.